Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Ernesto Sparrelid to Pancreatic Neoplasms

This is a "connection" page, showing publications Ernesto Sparrelid has written about Pancreatic Neoplasms.

 
Connection Strength
  
 
 
5.850
  
  1. Søreide K, Sparrelid E. Defining what is left in a left-sided pancreatectomy. Br J Surg. 2024 04 03; 111(4).
    View in: PubMed
    Score: 0.456
  2. Holmberg M, Radkiewicz C, Strömberg C, Öman M, Ghorbani P, Löhr JM, Sparrelid E. Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma - A Swedish nationwide register-based study. Pancreatology. 2023 Jan; 23(1):90-97.
    View in: PubMed
    Score: 0.417
  3. Holmberg M, Linder S, Kordes M, Liljefors M, Ghorbani P, Löhr JM, Sparrelid E. Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia - A comparison with pancreatic ductal adenocarcinoma. Pancreatology. 2022 Jun; 22(5):598-607.
    View in: PubMed
    Score: 0.398
  4. Linder S, Holmberg M, Engstrand J, Ghorbani P, Sparrelid E. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification? Surg Oncol. 2022 May; 41:101735.
    View in: PubMed
    Score: 0.395
  5. Holmberg M, Koppatz H, Jansson A, Hillingsø JG, Noergaard Larsen P, Lassen K, Sallinen V, Yaqub S, Sparrelid E. Secondary effects of the COVID-19 pandemic on surgical management of hepatopancreatobiliary malignancies in the Nordic capitals. Br J Surg. 2021 12 17; 109(1):e8-e9.
    View in: PubMed
    Score: 0.389
  6. Holmberg M, Ghorbani P, Gilg S, Del Chiaro M, Arnelo U, Löhr JM, Sparrelid E. Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma. Pancreatology. 2021 Oct; 21(7):1371-1377.
    View in: PubMed
    Score: 0.380
  7. Romell J, Moro CF, Brodin B, Szekely L, Porovic E, Tsagkozis P, Sparrelid E, Björnstedt M, Hertz HM. X-ray histology on rapidly fixed fresh tumor tissue samples for fast resection margin assessment. Sci Rep. 2026 Jul 11; 16(1).
    View in: PubMed
    Score: 0.134
  8. Stoop TF, Croce C, Ishida H, Ali M, Javed AA, Halimi A, Oba A, Groot Koerkamp B, Leonhardt CS, Thiels CA, Rangelova E, Sparrelid E, Sotirova I, Leiting JL, Tauchi J, Kobayashi K, Klos M, Beuk LPM, Genova L, Mastronardi M, Kendrick ML, Mughal NA, Busch OR, Franklin O, Larsson P, Klaiber U, Schulick RD, Theijse RT, Strobel O, Ghorbani P, de Wilde RF, Rodriguez Franco S, Sugawara T, Wilmink JW, Messersmith W, Besselink MG, Wolfgang CL, Inoue Y, Truty MJ, Del Chiaro M. Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study. BJS Open. 2026 05 12; 10(3).
    View in: PubMed
    Score: 0.132
  9. Stoop TF, van 't Land FR, Seelen LWF, Ali M, Sultan A, Javed AA, van Eijck CHJ, Thiels CA, Hewitt DB, Sparrelid E, Uzunoglu FG, Gehrisch OHF, Daams F, Ishida H, van Santvoort HC, Molenaar IQ, Leiting JL, Erdmann JI, Cappelle M, Ginesini M, Kendrick ML, Napoli N, Busch OR, Franklin O, Ghorbani P, Schulick RD, Dankha R, de Wilde RF, Welsch T, Te Riele W, Wolfgang CL, Besselink MG, Groot Koerkamp B, Boggi U, Truty MJ, Del Chiaro M, Hackert T. Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection. BJS Open. 2026 05 12; 10(3).
    View in: PubMed
    Score: 0.132
  10. Nilsson T, Rasinski P, Sparrelid E, Tzortzakakis A, Tran TA, Smedby Ö, Axelsson R, Lubberink M, Holstensson M. Kinetic modelling of [68Ga]Ga-FAPI-46 PET in pancreaticobiliary lesions: distinguishing cancer from pancreatitis. Eur J Nucl Med Mol Imaging. 2026 Jul; 53(9):5549-5559.
    View in: PubMed
    Score: 0.132
  11. Holmberg M, Dall'Olio T, Marwa M, Hansen CP, Kleive DB, Nappo G, Shi L, Sandström P, Björk D, Hadesi P, De Rosa RV, Andersson B, Ansari D, Chikkala B, Todeschini L, Leseman C, Schuitema J, Lodewijks Y, Månsson C, Delis S, Berrevoet F, Giannone F, Xenaki S, Pando E, Bertrand C, Vasileiadis K, Kirchweger P, Ciulla C, Luchini C, Luyer M, Besselink MG, Marchegiani G, Pandanaboyana S, Tingstedt B, Sulpice L, Wennerblom J, Björnsson B, Balakrishnan A, Labori KJ, Burgdorf SK, Qadan M, Sparrelid E, Pea A, Hernandez-Barco YG, Salvia R, Ghorbani P. Survival After Pancreatic Resection for Intraductal Papillary Mucinous Neoplasm: Supporting Selective Surgery. United European Gastroenterol J. 2026 Apr; 14(3):e70199.
    View in: PubMed
    Score: 0.131
  12. Aaquist T, Henriksen TV, Mariager Jakobsen LL, Fristrup CW, Pfeiffer P, de Stricker K, Sparrelid E, Moro CF, Mortensen F, Knudsen AR, Hamilton-Dutoit S, Kleeff J, Mortensen MB, Andersen CL, Detlefsen S. Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. Hum Pathol. 2026 Feb; 168:106024.
    View in: PubMed
    Score: 0.128
  13. Söderqvist S, Viljamaa A, Geyer N, Keller AL, Ruksha K, Strell C, Hekmati N, Niculae A, Engstrand J, Sparrelid E, Salmén C, Costa TDF, Zhao M, Strömblad S, Zacharouli A, Ghorbani P, Harrizi S, Hamidi Y, Khorosjutina O, Milanova S, Schmierer B, Bozóky B, Fernández Moro C, Gerling M. An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer. Nat Commun. 2025 Sep 26; 16(1):8307.
    View in: PubMed
    Score: 0.126
  14. Suljagic A, Swartling O, Henningson ES, Ansorge C, Gilg S, Sparrelid E, Ghorbani P. Postoperative Cholangitis After Pancreatoduodenectomy: A Frequent Late Complication Demanding Standardized Prevention and Treatment Protocols. Ann Surg Oncol. 2025 Dec; 32(13):10007-10016.
    View in: PubMed
    Score: 0.126
  15. Hasselgren K, Williamsson C, Wennerblom J, Ghorbani P, Liljefors MG, Huhta H, Heby M, Månsson C, Johansson MI, Elander NO, Nortunen M, Kallio R, Halimi A, Öhlund D, Sandström P, Sparrelid E, Björnsson B. Prospective evaluation of surgical treatment of liver metastasizing pancreatic cancer - ScanPan study protocol. BMC Surg. 2025 Jul 19; 25(1):299.
    View in: PubMed
    Score: 0.125
  16. Bonsdorff A, Kjeseth T, Sahakyan M, Kirkegård J, de Ponthaud C, Ghorbani P, Wennerblom J, Williamson C, Acher AW, Thillai M, Tarvainen T, Uutela A, Sirén J, Kokkola A, Hagen RE, Lund A, Nielsen MF, Fristedt R, Biörserud C, Bratlie SO, Tingstedt B, Labori KJ, Gaujoux S, Wigmore SJ, Hallet J, Sparrelid E, Kleive D, Sallinen V. Impact of neoadjuvant therapy on short-term outcomes after left pancreatectomy: A propensity score-matched international multicenter study. Surgery. 2025 Sep; 185:109552.
    View in: PubMed
    Score: 0.125
  17. Perri G, Engstrand J, Wright RD, Bronzwaer SFC, Kroese TE, Huang B, Acidi B, Vitale A, Tran Cao HS, van Hillegersberg R, Nilsson M, Sparrelid E, Katz MHG, Marchegiani G, Cillo U. The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open. 2025 07 01; 9(4).
    View in: PubMed
    Score: 0.124
  18. Rompen IF, Stoop TF, van Roessel S, van Veldhuisen E, Janssen QP, Alseidi A, Balduzzi A, Balzano G, Berrevoet F, Bonds M, Busch OR, Butturini G, Javed AA, Del Chiaro M, Conlon KC, Falconi M, Frigerio I, Fusai GK, Gagnière J, Griffin O, Hackert T, Sparrelid E, Halimi A, Labori KJ, Malleo G, Marino MV, Mortensen MB, Nikov A, Lesurtel M, Keck T, Kleeff J, Pandé R, Pfeiffer P, Pietrasz D, Roberts KJ, Sa Cunha A, Salvia R, Strobel O, Tarvainen T, van Laarhoven HWM, Groot Koerkamp B, Loos M, Michalski CW, Besselink MG, Hank T. Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Ann Surg. 2025 May 01; 281(5):852-860.
    View in: PubMed
    Score: 0.121
  19. Rangelova EB, Ghorbani P, Valente R, Tanaka K, Halimi A, Arnelo U, Segersvärd R, Sparrelid E, Del Chiaro M. Overcoming the technical challenge of venous resection with pancreatectomy: Which factors determine survival? Eur J Surg Oncol. 2025 08; 51(8):109629.
    View in: PubMed
    Score: 0.121
  20. Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, Löhr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
    View in: PubMed
    Score: 0.121
  21. Rangelova E, Stoop TF, van Ramshorst TME, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, Steyerberg E, Banerjee A, Jain A, Sauvanet A, Serrablo A, Giani A, Giardino A, Zerbi A, Arshad A, Wijma AG, Coratti A, Zironda A, Socratous A, Rojas A, Halimi A, Ejaz A, Oba A, Patel BY, Björnsson B, Reames BN, Tingstedt B, Goh BKP, Payá-Llorente C, Del Pozo CD, González-Abós C, Medin C, van Eijck CHJ, de Ponthaud C, Takishita C, Schwabl C, Månsson C, Ricci C, Thiels CA, Douchi D, Hughes DL, Kilburn D, Flanking D, Kleive D, Silva DS, Edil BH, Pando E, Moltzer E, Kauffman EF, Warren E, Bozkurt E, Sparrelid E, Thoma E, Verkolf E, Ausania F, Giannone F, Hüttner FJ, Burdio F, Souche FR, Berrevoet F, Daams F, Motoi F, Saliba G, Kazemier G, Roeyen G, Nappo G, Butturini G, Ferrari G, Kito Fusai G, Honda G, Sergeant G, Karteszi H, Takami H, Suto H, Matsumoto I, Mora-Oliver I, Frigerio I, Fabre JM, Chen J, Sham JG, Davide J, Urdzik J, de Martino J, Nielsen K, Okano K, Kamei K, Okada K, Tanaka K, Labori KJ, Goodsell KE, Alberici L, Webber L, Kirkov L, de Franco L, Miyashita M, Maglione M, Gramellini M, Ramera M, Amaral MJ, Ramaekers M, Truty MJ, van Dam MA, Stommel MWJ, Petrikowski M, Imamura M, Hayashi M, D'Hondt M, Brunner M, Hogg ME, Zhang C, Suárez-Muñoz MÁ, Luyer MD, Unno M, Mizuma M, Janot M, Sahakyan MA, Jamieson NB, Busch OR, Bilge O, Belyaev O, Franklin O, Sánchez-Velázquez P, Pessaux P, Holka PS, Ghorbani P, Casadei R, Sartoris R, Schulick RD, Grützmann R, Sutcliffe R, Mata R, Patel RB, Takahashi R, Rodriguez Franco S, Cabús SS, Hirano S, Gaujoux S, Festen S, Kozono S, Maithel SK, Chai SM, Yamaki S, van Laarhoven S, Mieog JSD, Murakami T, Codjia T, Sumiyoshi T, Karsten TM, Nakamura T, Sugawara T, Boggi U, Hartman V, de Meijer VE, Bartholomä W, Kwon W, Koh YX, Cho Y, Takeyama Y, Inoue Y, Nagakawa Y, Kawamoto Y, Ome Y, Soonawalla Z, Uemura K, Wolfgang CL, Jang JY, Padbury R, Satoi S, Messersmith W, Wilmink JW, Abu Hilal M, Besselink MG, Del Chiaro M. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Ann Oncol. 2025 05; 36(5):529-542.
    View in: PubMed
    Score: 0.120
  22. Andel PCM, van Goor IWJM, Augustinus S, Berrevoet F, Besselink MG, Bhojwani R, Boggi U, Bouwense SAW, Cirkel GA, van Dam JL, Djanani A, Dorcaratto D, Dreyer S, den Dulk M, Frigerio I, Ghorbani P, Goetz MR, Groot Koerkamp B, Gryspeerdt F, Hidalgo Salinas C, Intven M, Izbicki JR, Jorba Martin R, Kauffmann EF, Klug R, Liem MSL, Luyer MDP, Maglione M, Martin-Perez E, Meerdink M, de Meijer VE, Nieuwenhuijs VB, Nikov A, Nunes V, Pando E, Radenkovic D, Roeyen G, Sanchez-Bueno F, Serrablo A, Sparrelid E, Tepetes K, Thakkar RG, Tzimas GN, Verdonk RC, Ten Winkel M, Zerbi A, Groot VP, Molenaar IQ, Daamen LA, van Santvoort HC. Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma. JAMA Surg. 2025 Jan 01; 160(1):74-84.
    View in: PubMed
    Score: 0.120
  23. Radkiewicz C, Ludvigsson JF, Sparrelid E, Emilsson L. Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study. Eur J Cancer. 2025 Jan; 214:115140.
    View in: PubMed
    Score: 0.119
  24. Larsson P, Swartling O, Cheraghi D, Khawaja A, Soreide K, Sparrelid E, Ghorbani P. Assessment of Outcomes by Intention-to-Treat Comparison for Locally Advanced Pancreatic Cancer: A Population-Derived Cohort Study. Ann Surg Oncol. 2025 Jan; 32(1):508-516.
    View in: PubMed
    Score: 0.118
  25. Coppola A, La Vaccara V, Farolfi T, Asbun HJ, Boggi U, Conlon K, Edwin B, Ferrone C, Jonas E, Kokudo N, Perez EM, Satoi S, Sparrelid E, Stauffer J, Zerbi A, Takemura N, Lai Q, Almerey T, Bernon M, Cammarata R, Djoumi Y, Gallagher T, Ghorbani P, Ginesini M, Hashimoto D, Kauffmann EF, Kleive D, Lluís N, González RM, Napoli N, Nappo G, Nebbia M, Ricchitelli S, Sahakyan MA, Yamamoto T, Coppola R, Caputo D. Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria. Int J Surg. 2024 Oct 01; 110(10):6092-6099.
    View in: PubMed
    Score: 0.118
  26. Uijterwijk BA, Moekotte A, Boggi U, Mazzola M, Groot Koerkamp B, Valle RD, Mazzotta A, Luyer M, Kazemier G, Ielpo B, Suarez Muñoz MA, Bolm L, Björnsson B, Pessaux P, Kleeff J, Fusai GK, Sparrelid E, Zerbi A, Lemmers DH, Alseidi A, Vladimirov M, Roberts KJ, Salvia R, Soonawalla Z, Korkolis D, Serradilla-Martín M, Mavroeidis VK, Bouwense SAW, Besselink MG, Abu Hilal M. Outcome of Minimally Invasive and Open Pancreatoduodenectomy in Patients With Intestinal and Pancreatobiliary Subtype Ampullary Cancer: An International Multicenter Cohort Study. Ann Surg. 2026 May 01; 283(5):848-854.
    View in: PubMed
    Score: 0.117
  27. Ansari D, Søreide K, Andersson B, Hansen CP, Seppänen H, Sparrelid E, Labori KJ, Kirkegård J, Kauhanen S, Månsson C, Nymo LS, Nortunen M, Björnsson B, Kivivuori A, Tingstedt B, Bratlie SO, Waardal K, Laukkarinen J, Halimi A, Lindberg H, Olin H, Andersson R. Surveillance after surgery for pancreatic cancer: a global scoping review of guidelines and a nordic Survey of contemporary practice. Scand J Gastroenterol. 2024 09; 59(9):1097-1104.
    View in: PubMed
    Score: 0.116
  28. Uijterwijk BA, Lemmers DH, Fusai GK, Zerbi A, Salvia R, Sparrelid E, White S, Björnsson B, Mavroeidis VK, Roberts KJ, Mazzola M, Cabús SS, Soonawalla Z, Korkolis D, Serradilla M, Pessaux P, Luyer M, Mowbray N, Ielpo B, Mazzotta A, Kleeff J, Boggi U, Muñoz MAS, Goh BKP, Andreotti E, Wilmink H, Ghidini M, Zaniboni A, Verbeke C, Adsay V, Bianchi D, Besselink MG, Abu Hilal M. Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review. Ann Surg Oncol. 2024 Jul; 31(7):4654-4664.
    View in: PubMed
    Score: 0.114
  29. Gorchs L, Fernández-Moro C, Asplund E, Oosthoek M, Solders M, Ghorbani P, Sparrelid E, Rangelova E, Löhr MJ, Kaipe H. Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer. Cancer Res Commun. 2024 02 19; 4(2):460-474.
    View in: PubMed
    Score: 0.113
  30. Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D, Klint L, Dueland S, Lassen K. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2024 03; 9(3):205-217.
    View in: PubMed
    Score: 0.112
  31. Rasinski P, Af Burén S, Holstensson M, Nilsson T, Loizou L, Tran TA, Sparrelid E, Löhr JM, Axelsson R. Tumor Characterization by [68Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial. J Nucl Med. 2023 08; 64(8):1232-1237.
    View in: PubMed
    Score: 0.108
  32. Djoumi Y, Sadr-Azodi O, Vujasinovic M, Del Chiaro M, Sparrelid E, Ghorbani P, Holmberg M. Pre-emptive resection for intraductal papillary mucinous neoplasia - Long-term outcome is similar between non-invasive and early invasive lesions in a tertiary single center. Pancreatology. 2023 Jun; 23(4):389-395.
    View in: PubMed
    Score: 0.106
  33. Nikolic S, Ghorbani P, Pozzi Mucelli R, Ghazi S, Baldaque-Silva F, Del Chiaro M, Sparrelid E, Verbeke CS, Löhr JM, Vujasinovic M. Surgery in Autoimmune Pancreatitis. Dig Surg. 2022; 39(1):32-41.
    View in: PubMed
    Score: 0.097
  34. Bergquist E, Kartalis N, Sparrelid E, Löhr M, Ghorbani P. [Intraductal papillary mucinous cystic neoplasm and other common cystic pancreatic lesions]. Lakartidningen. 2021 10 05; 118.
    View in: PubMed
    Score: 0.096
  35. Larsson P, Swartling O, Perri G, Vaez K, Holmberg M, Klevebro F, Gilg S, Sparrelid E, Ghorbani P. The impact of chronic obstructive pulmonary disease on risk for complications after pancreatoduodenectomy - a single centre cohort study. HPB (Oxford). 2025 Jan; 27(1):87-93.
    View in: PubMed
    Score: 0.030
  36. Nilsson T, Rasinski P, Smedby Ö, Af Burén S, Sparrelid E, Löhr JM, Tran TA, Blomgren A, Tzortzakakis A, Axelsson R, Holstensson M. Acquisition Duration Optimization Using Visual Grading Regression in [68Ga]FAPI-46 PET Imaging of Oncologic Patients. J Nucl Med Technol. 2024 Sep 05; 52(3):221-228.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)